P. D. Benedetto

发表

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

A. Manzo, F. Ciccia, R. Giacomelli, 2013, Arthritis Research & Therapy.

Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.

R. Giacomelli, P. Ruscitti, P. Cipriani, 2020, Autoimmunity reviews.

The Journal of Rheumatology Development of Fibrosis Activated ADAM 12 and Are Involved in Myofibroblast Transdifferentiation and Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis

Edoardo, G. Guggino, F. Ciccia, 2016 .

Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

A. F. Campese, I. Screpanti, R. Giacomelli, 2013, Angiogenesis.

promotes TGFβ signaling and fibrosis in systemic sclerosis.

K. Kaestner, S. Jimenez, N. Bottini, 2017 .

Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

A. F. Campese, I. Screpanti, R. Giacomelli, 2013, Angiogenesis.

Ciccia, F. et al. (2017) Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis

Triolo, A. Gabrielli, A. Fasano, 2017 .

Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells

I. Screpanti, R. Giacomelli, E. Alesse, 2015 .

Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS

F. Ciccia, R. Giacomelli, G. Amicucci, 2013, Expert review of clinical immunology.

Potential of stem cells in the treatment of rheumatic disease

R. Giacomelli, P. Ruscitti, V. Liakouli, 2014 .

Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases.

R. Giacomelli, P. Ruscitti, P. D. Benedetto, 2019, Autoimmunity reviews.

H‐ferritin and CD68+/H‐ferritin+ monocytes/macrophages are increased in the skin of adult‐onset Still's disease patients and correlate with the multi‐visceral involvement of the disease

G. Guggino, F. Ciccia, R. Giacomelli, 2016, Clinical and experimental immunology.

The CD68+/H‐ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H‐ferritin in the same tissue: correlation with disease severity and implication for pathogenesis

A. Rizzo, G. Guggino, F. Ciccia, 2016, Clinical and experimental immunology.

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in

F. Ciccia, R. Giacomelli, P. Ruscitti, 2015, Clinical and experimental immunology.

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular‐based therapy

R. Giacomelli, E. Alesse, P. Di Benedetto, 2013, Clinical and experimental immunology.

H‐ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome

G. Guggino, F. Ciccia, R. Giacomelli, 2018, Clinical and experimental immunology.

Title Page Title: H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome Short title: H-ferritin in MAS

G. Guggino, P. Ruscitti, O. Berardicurti, 2017 .